Chardan Healthcare Acquisition 2 Corp. (CHAQ) to Combine with Renovacor, Inc. in $84.6M Deal

Mar 23, 2021 INTEL by Nicholas Alan Clayton

Chardan Healthcare 2 (NYSE:CHAQ) has entered into a definitive agreement to combine with biotech firm Renovacor at an implied transaction value of $84.6 million. Philadelphia-based Renovacor is developing gene therapies targeting the BAG3 protein to treat heart conditions. The combined company is expected to trade on the NYSE under the symbol “RCOR” once the deal
Read More

To access this post, you must purchase a Monthly or Yearly SPACInsider Subscription, or log in if you're a member.

Chardan Healthcare Acquisition 2 Corp. (CHAQ) to Combine with Renovacor, Inc. in $84.6M Deal

Chardan Healthcare Acquisition 2 Corp. (CHAQ) to Combine with Renovacor, Inc. in $84.6M Deal

ByNicholas Alan Clayton